ENSYSCE BIOSCIENCES, INC. Operating Lease Right-of-Use Assets
ENSYSCE BIOSCIENCES, INC. (ENSC) had Operating Lease Right-of-Use Assets of $9.41 thousand as of 2021-06-30, per its 10-Q filed 2021-08-16.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2021-08-16
- 2021-06-30: Operating Lease, Right-of-Use Asset $9.41K.
- 2020-12-31: Operating Lease, Right-of-Use Asset $23.54K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2021-06-30 | $9.41K 10-Q · filed 2021-08-16 |
| 2020-12-31 | $23.54K 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |